Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
Pozycja w akcjach
#2197
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical... Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Cena akcji
$3.40
Kapitalizacja rynkowa
$9.07B
Zmiana (1 dzień)
-1.61%
Zmiana (1 rok)
-16.08%
Kraj
CN
Handel Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
Kategoria
Healthcare
Marża operacyjna dla Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
Marża operacyjna na dzień 2026 TTM: 0.00%
Według najnowszych raportów finansowych i ceny akcji Shanghai Fosun Pharmaceutical (Group) Co., Ltd., bieżąca marża operacyjna (TTM) wynosi 0.00%. Na koniec 2026 wynosiła 0.00%.
Historia marży operacyjnej dla Shanghai Fosun Pharmaceutical (Group) Co., Ltd. od 2001 do 2026
Marża operacyjna na koniec każdego roku
| Rok | Marża operacyjna | Zmień |
|---|---|---|
| 2025 | 6.08% | -41.20% |
| 2024 | 10.34% | 29.41% |
| 2023 | 7.99% | -24.55% |
| 2022 | 10.59% | -34.47% |
| 2021 | 16.16% | 3.72% |
| 2020 | 15.58% | -0.89% |
| 2019 | 15.72% | 10.78% |
| 2018 | 14.19% | -35.47% |
| 2017 | 21.99% | -5.22% |
| 2016 | 23.20% | -11.28% |
| 2015 | 26.15% | 31.34% |
| 2014 | 19.91% | 84.69% |
| 2013 | 10.78% | 33.25% |
| 2012 | 8.09% | -66.80% |
| 2011 | 24.37% | -2.68% |
| 2010 | 25.04% | 422.76% |
| 2009 | 4.79% | 29.81% |
| 2008 | 3.69% | -81.50% |
| 2007 | 19.95% | 142.11% |
| 2006 | 8.24% | 4.97% |
| 2005 | 7.85% | 64.92% |
| 2004 | 4.76% | -68.41% |
| 2003 | 15.07% | -7.72% |
| 2002 | 16.33% | -17.48% |
| 2001 | 19.79% | 0.00% |
Marża operacyjna dla podobnych firm lub konkurentów
| Firma | Marża operacyjna | Różnica w marży operacyjnej | Kraj |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 0.00% | - |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | - |
IN
|
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.